Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Sah P, Shoukat A, Meyers LA, Galvani AP, Population immunity against COVID-19 in the United States, Annals of Internal Medicine 2021, 174(11):1586-1591.
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer BH, McDonald RH, Fitzpatrick MC, Galvani AP, Optimizing COVID-19 quarantine and testing strategies, Nature Communications 2021, 21: 356.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Bowman CS, Arino J, Moghadas SM, Evaluation of vaccination strategies during pandemic outbreaks, Mathematical Biosciences and Engineering 2011, 8: 117–125.
Wessel L, Hua Y, Wu J, Moghadas SM, Public health interventions for epidemics: implications for multiple infection waves, BMC Public Health 2011, 11 (Suppl 1): S2.
Arino J, Bauch CT, Brauer F, Driedger SM, Greer AL, Moghadas SM, Pizzi NJ, Sander B, Tuite A, van den Driessche P, Watmough J, Wu J, Yan P, Pandemic influenza: modelling and public health perspectives, Mathematical Biosciences and Engineering 2011, 8: 1–20.
Mostaco–Guidolin LC, Pizzi NJ, Demko AB, Moghadas SM, A software development framework for agent–based infectious disease modelling, Biomedical Engineering, Trends, Researches and Technologies, In–Tech, 2011, Chapter 33, pp. 641–664.
Moghadas SM, Dynamics of resistance in influenza with compensatory mutations, Mathematical Population Studies 2011, 18: 106–121.
Rathi N, Moghadas SM, Shivakumar PN, Therapeutic modelling of diabetes type 1, Type 1 Diabetes – Complications, Pathogenesis, and Alternative Treatments. In–Tech, 2011 Chapter 22, pp. 461–470.
Conway JM, Tuite AR, Fisman DN, Hupert N, Meza R, Davoudi B, English K, van den Driessche P, Brauer F, Ma J, Meyers LA, Smieja M, Greer AL, Skowronski DM, Buckeridge DL, Kwong JC, Wu J, Moghadas SM, Coombs D, Brunham RC, Pourbohloul B, Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything, BMC Public Health 2011, 11: 932.
Duvvuri VRSK, Moghadas SM, Guo H, Duvvuri B, Heffernan J, Fisman DN, Wu GE, Wu J, Highly conserved cross–reactive CD4+ T–cell HA–epitopes of seasonal and the 2009 pandemic influenza viruses, Influenza and Other Respiratory Viruses 2010, 4: 249–258.
Hansen E, Day T, Arino J, Wu J, Moghadas SM, Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks, Canadian Journal of Infectious Diseases and Medical Microbiology 2010, 21: e28–e63.
Tuite AR, Greer AL, Whelan M, Winter A–L, Yan P, Wu J, Moghadas SM, Buckeridge D, Pourbohloul B, Fisman DN, Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza, Canadian Medical Association Journal 2010, 182: 131–136.